Faculty Collaboration Database

Pediatric Orbital Cellulitis/Abscess: Microbiology and Pattern of Antibiotic Prescribing. WMJ 2023 Mar;122(1):52-55

Date

03/21/2023

Pubmed ID

36940123

Scopus ID

2-s2.0-85150751891 (requires institutional sign-in at Scopus site)

Abstract

INTRODUCTION: The treatment for pediatric orbital cellulitis/abscess is trending towards intravenous antibiotic management alone in appropriate cases. Without cultures to guide therapy, knowing the local microbiology is of utmost importance in managing these patients.

METHODS: We conducted a retrospective case series for patients age 2 months to 17 years, who were hospitalized between January 1, 2013, and December 31, 2019, to evaluate the local microbiology and pattern of antibiotic prescribing in pediatric orbital cellulitis.

RESULTS AND DISCUSSION: Of 95 total patients, 69 (73%) received intravenous antibiotics only and 26 (27%) received intravenous antibiotics plus surgery. The most common organism cultured was Streptococcus anginosus, followed by Staphylococcus aureus, and group A streptococcus. Methicillin-resistant Staphylococcus aureus (MRSA) prevalence was 9%. MRSA-active antibiotics remain the most frequently used antibiotics.

Author List

Burek AG, Tregoning G, Pan A, Liegl M, Harris GJ, Havens PL

Authors

Alina G. Burek MD Assistant Professor in the Pediatrics department at Medical College of Wisconsin
Gerald J. Harris MD Professor in the Ophthalmology and Visual Sciences department at Medical College of Wisconsin
Amy Y. Pan PhD Associate Professor in the Pediatrics department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Abscess
Anti-Bacterial Agents
Child
Humans
Methicillin-Resistant Staphylococcus aureus
Orbital Cellulitis
Retrospective Studies
Staphylococcal Infections